Essen BioScience, Inc.
  • Status Prior Investment
  • Location Ann Arbor, Michigan
  • Industry Industrial & Healthcare Technology
  • Themes Life Sciences tools
  • Investment Date May 2014
  • Exit April 2017

About

Essen Bioscience is a leading provider of analytical instrumentation, software, reagents and services used in cell-based life sciences research.

Value proposition

Provides researchers unparalleled access to quantitative, kinetic cellular biology while improving data quality and streamlining image collection through automation of the cell analysis process.

Customers

Leading biopharmaceutical, academic and research institutions around the globe. Its products are used in labs focused on cell production, microscopy/imaging, assay development and screening.

Key Initiatives
  • Talent: recruited key executives across the organization
  • New Product Development: added new high-margin recurring revenue streams through commercializing reagents and consumables
  • Sales and Marketing: doubled the size of the sales team while upgrading sales processes and related tracking information systems; launched application-specific marketing initiatives; greatly improved lead generation capabilities
  • Finance and Infrastructure: implemented new financial reporting and information systems; upgraded to new manufacturing facility

Related News
Feb 20 2019
SFW Capital Partners attended SLAS 2019 in Washington, D.C.
Apr 3 2017
SFW Capital Partners Completes Sale of Essen BioScience to Sartorius Group AG
Oct 11 2016
Using Continuous Live-Cell Analysis to Meet New Requirements of Cellular Research
Jan 28 2015
Essen BioScience, Inc. Appoints Jim Ryder as Global Head of Sales
Oct 8 2014
Essen BioScience Appoints Brett Williams as President and CEO
Sep 15 2014
Essen BioScience Launches New Product: NeuroPrime Cell Kit
May 14 2014
SFW Capital Partners Makes a Strategic Investment in Essen Bioscience